key: cord-0908584-rirhb0j1
authors: Kounis, Ilias; Duhaut, Lea; Breard, Thomas; Samuel, Didier; Coilly, Audrey
title: Impact of COVID – 19 in patients awaiting liver transplantation
date: 2021-11-29
journal: Liver Int
DOI: 10.1111/liv.15105
sha: b852024c0b09097218db6930275e8d993a675d7a
doc_id: 908584
cord_uid: rirhb0j1

We read with interest the review article "Impact of chronic liver disease on outcomes of hospitalized patients with COVID-19: A multicentre United States experience" published in the July 2020 issue of Liver International (PMID: 32585065) 1 . Although the review brings very important information regarding COVID-19 in patient with underlying liver disease, we observed that information regarding patients awaiting liver transplantation were missing.

Dear Editor,

We read with interest the review article "Impact of chronic liver disease on outcomes of hospitalized patients with COVID-19: A multicentre United States experience" published in the July 2020 issue of Liver International (PMID: 32585065). 1 Although the review brings very important information regarding COVID-19 in patient with underlying liver disease, we observed that information regarding patients awaiting liver transplantation was missing. This is the reason why we would like to share our experience of patients awaiting liver transplantation during the first wave of the COVID pandemic.

During this period, for more than 1 month, our hospital was overwhelmed by patients needing care for COVID-19. 2, 3 The result was unfortunately to break our previous continuous contact with the patients awaiting liver transplantation. On the other hand, liver transplantation was never discontinued in France, even though the activity in liver transplantation centres slowed down. Precisely, according to our public institution which regulates organ procurement and transplantation, the activity of liver transplantation decreased by 17% during 2020 in France compared to 2019.

In this context, we wanted to keep in touch with our patients and understand their point of view regarding the pandemic. For this reason, we built a questionnaire that was sent to all patients on waiting list for liver transplantation between 15 April and 15 May 2020 in Hepatobiliary Center of Paul Brousse Hospital, France. The questionnaire was sent either by email or filled up instantly after a phone call.

We defined as "suspect for COVID-19" the patients with symptoms suggesting COVID-19 or those who had a contact with a confirmed COVID-19 person. We defined as "certain for COVID-19" the patients with positive PCR or compatible CT scan features. No patient in our waiting list died before liver transplantation.

The second information we extracted from our questionnaire is the impact of COVID-19 in terms of drop-out from waiting list. Two On the one hand, patients awaiting liver transplantation appear to be at greater risk of a severe COVID-19 because of their disease that exposes them to a higher mortality. On the other hand, these patients are probably less exposed to COVID-19 as they strictly respect the lockdown rules. However, except from preventive measures like face masks, hand hygiene and physical distancing, anti SARS-COV2 vaccination should be recommended for these high-risk patients.

Impact of chronic liver disease on outcomes of hospitalized patients with COVID-19: a multicentre United States experience

Declining cirrhosis hospitalizations in the wake of the COVID-19 pandemic: a national cohort study

Evolution of outcomes for patients hospitalised during the first 9 months of the SARS-CoV-2 pandemic in France: a retrospective national surveillance data analysis

Comparison of mortality risk in patients with cirrhosis and COVID-19 compared with patients with cirrhosis alone and COVID-19 alone: multicentre matched cohort

centres contributing to the ELITA-ELTR COVID-19 Registry. COVID-19 in liver transplant candidates: pretransplant and post-transplant outcomes -an ELITA/ ELTR multicentre cohort study